文献速递认知障碍与痴呆

扩大的血管周围间隙与阿尔茨海默病连续体中的淀粉样蛋白负荷及认知下降的相关性

Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum.
PubMed 文献 · Neurology · 2022-10-17

该研究回顾性纳入208例经18F-florbetaben PET证实淀粉样蛋白沉积的阿尔茨海默病连续体患者及82名健康对照,分析基底节、半卵圆中心和海马扩大的血管周围间隙与淀粉样蛋白负荷及认知功能的关系。结果显示各部位扩大的血管周围间隙在诊断时与淀粉样蛋白负荷或认知功能独立于小血管病标志物无显著关联,但半卵圆中心扩大的血管周围间隙与MMSE评分更快速下降显著相关(β=-0.58,标准误=0.23,p=0.011),且独立于淀粉样蛋白负荷。

要点

  • 基底节、半卵圆中心和海马扩大的血管周围间隙在诊断时与淀粉样蛋白负荷无显著关联。
  • 半卵圆中心扩大的血管周围间隙数量较多与MMSE评分更快速下降显著相关(β=-0.58,p=0.011)。
  • 基底节和海马扩大的血管周围间隙阳性组与阴性组MMSE纵向下降速率无差异。

核心结论

  • 基底节、半卵圆中心和海马扩大的血管周围间隙在阿尔茨海默病连续体诊断时与小血管病标志物无关,且不与基线β-淀粉样蛋白负荷或认知功能相关。
  • 半卵圆中心扩大的血管周围间隙似乎以非淀粉样蛋白依赖的方式与认知下降进展相关。
  • 需要进一步研究以探究半卵圆中心扩大的血管周围间隙是否为阿尔茨海默病连续体患者的潜在治疗靶点。

研究设计与样本

  • 回顾性研究纳入208例经18F-florbetaben PET显示淀粉样蛋白沉积的阿尔茨海默病连续体患者(临床前、前驱期和阿尔茨海默病痴呆)及82名健康对照。
  • 在轴位T2加权图像上计数基底节、半卵圆中心和海马的扩大的血管周围间隙。
  • 基底节和半卵圆中心按扩大的血管周围间隙数量分为EPVS+组(>10个)和EPVS-组(0-10个);海马扩大的血管周围间隙以双侧半球≥7个视为存在。
  • 调整小血管病标志物后,采用多元线性回归分析组间全局和区域淀粉样蛋白沉积及诊断时认知功能的差异,采用线性混合模型评估扩大的血管周围间隙对MMSE评分纵向变化的影响。

主要发现

  • 阿尔茨海默病连续体诊断时淀粉样蛋白负荷与基底节、半卵圆中心或海马扩大的血管周围间隙程度无关联。
  • 基底节扩大的血管周围间隙通过小血管病标志物影响语言和额叶/执行功能,海马扩大的血管周围间隙通过小血管病标志物与一般认知相关。
  • 半卵圆中心扩大的血管周围间隙与基线认知无关。
  • 半卵圆中心扩大的血管周围间隙数量较多与MMSE评分更快速下降显著相关(β=-0.58,标准误=0.23,p=0.011),独立于淀粉样蛋白负荷。
  • 基底节和海马扩大的血管周围间隙阳性组与阴性组之间MMSE评分纵向下降速率无差异。

关键数值与推荐

  • 基底节和半卵圆中心扩大的血管周围间隙分组阈值:EPVS+为>10个,EPVS-为0-10个。
  • 海马扩大的血管周围间隙存在定义为双侧半球≥7个。
  • 半卵圆中心扩大的血管周围间隙与MMSE下降的线性混合模型结果:β=-0.58,标准误=0.23,p=0.011。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以探究半卵圆中心扩大的血管周围间隙是否为阿尔茨海默病连续体患者的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To investigate the effects of enlarged perivascular space (EPVS) on amyloid burden and cognitive function in Alzheimer disease (AD) continuum. METHODS: We retrospectively reviewed 208 patients with AD across the cognitive continuum (preclinical, prodromal, and AD dementia) who showed amyloid deposition on 18F-florbetaben PET scans and 82 healthy controls. EPVSs were counted for each patient in the basal ganglia (BG), centrum semiovale (CSO), and hippocampus (HP) on axial T2-weighted images. Patients were then classified according to the number of EPVSs into the EPVS+ (>10 EPVSs) and EPVS- (0-10 EPVSs) groups for the BG and CSO, respectively. In terms of HP-EPVS, equal or more than 7 EPVSs on bilateral hemisphere were regarded as the presence of HP-EPVS. After adjusting for markers of small vessel disease (SVD), multiple linear regression analyses were performed to determine the intergroup differences in global and regional amyloid deposition and cognitive function at the time of diagnosis of AD continuum. A linear mixed model was used to assess the effects of EPVSs on the longitudinal changes in the Mini-Mental State Examination (MMSE) scores. RESULTS: Amyloid burden at the time of diagnosis of AD continuum was not associated with the degree of BG-, CSO-, or HP-EPVS. BG-EPVS affected language and frontal/executive function via SVD markers, and HP-EPVS was associated with general cognition via SVD markers. However, CSO-EPVS was not associated with baseline cognition. A higher number of CSO-EPVS was significantly associated with a more rapid decline in MMSE scores (β = -0.58, standard error = 0.23, p = 0.011) independent of the amyloid burden. In terms of BG and HP, there was no difference between the EPVS+ and EPVS- groups in the rate of longitudinal decreases in MMSE scores. DISCUSSION: Our findings suggest that BG-, CSO-, and HP-EPVS are not associated with baseline β-amyloid burden or cognitive function independently of SVD at the diagnosis of AD continuum. However, CSO-EPVS appears to be associated with the progression of cognitive decline in an amyloid-independent manner. Further studies are needed to investigate whether CSO-EPVS is a potential therapeutic target in patients with AD continuum.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jeong SH, Cha J, Park M, et al. Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum. Neurology. 2022. PMID: 35985826. doi:10.1212/WNL.0000000000200989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。